1 |
Beaumont A, Hughes J: Biology of opioid peptides. Annu Rev Pharmacol Toxicol 1979; 19: 245-67
DOI
ScienceOn
|
2 |
Bunzow JR, Saez C, Mortrud M, Bouvier C, Williams JT, Low M, et al: Molecular cloning and tissue distribution of a putative member of the rat opioid recepror gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett 1994; 347: 284-8
DOI
ScienceOn
|
3 |
Harrison LM, Kastin AJ, Zadina JE: Opiate tolerance and dependence: receptors, G-ptoteins, and antiopiates. Peptides 1998; 19: 1603-30
DOI
ScienceOn
|
4 |
Ross EM, Wilkie TM: GTPase-activating proteins for hetetotri-meric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu Rev Biochem 2000; 69: 795-827
DOI
ScienceOn
|
5 |
Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Garcia-Espana A, Sanchez-Blazquez P: RGSZ1 and GAIP regulate - but not -opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance. Neuropsychopharmacology 2004; 29: 1091-104
DOI
ScienceOn
|
6 |
Potenza MN, Gold SJ, Roby-Shemkowitz A, Lernet MR, Nestlet EJ: Effects of regulatots of G protein-signaling ptoteins on the functional response of the -opioid teceptor in a melanophore-based assay. J Pharmacol Exp Ther 1999; 291: 482-91
|
7 |
Ulens C, Daenens P, Tytgat J: Changes in GIRK1/GIRK2 deactivation kinetics and basal activity in the presence and absence of RGS4. Life Sci 2000; 67: 2305-17
DOI
ScienceOn
|
8 |
Bishop GB, Cullman WE, Curran E, Gutstein HB: Abused drugs modulate RGS4 mRNA levels in tat brain: comparison between acute dtug treatment and a dtug challenge aftet chronic treatment. Neurobiol Dis 2002; 10: 334-43
DOI
ScienceOn
|
9 |
Narita M, Mizuo K, Shibasaki M, Natita M, Suzuki T: Up-regulation of the Gq/ protein and protein kinase C duting the development of sensitization to morphine-induced hyperloco-motion. Neuroscience 2002; 111: 127-32
DOI
ScienceOn
|
10 |
Saitoh O, Masuho I, Tetakawa I, Nomoto S, Asano T, Kubo Y: Regulator of G protein signaling 8 (RGS8) tequites its NH2 terminus for subcellular localization and acute desensirization of G protein-gated $K^{+}$ channels. J Biol Chem 2001; 276: 5052-8.
DOI
ScienceOn
|
11 |
Zhang JH, Barr VA, Mo Y, Rojkova AM, Liu S, Simonds WF: Nuclear localization of G protein and regulator of G protein signaling 7 in neurons and brain. J Biol Chem 2001; 276: 10284-9
DOI
ScienceOn
|
12 |
Sanchez-Blazquez P, Rodriguez-Diaz M, Lopez-Fando A, Rodriguez-Muiioz M, Garzon J: The GBeta5 subunit that associates with the R7 subfamily of RGS proteins regulates mu-opioid effecrs. Neuropharmacology 2003; 45: 82-95
DOI
ScienceOn
|
13 |
Hollinger S, Hepler JR: Cellular regulation of RGS ptoteins: modulatots and integrators of G protein signaling. Pharmacol Rev 2002; 54: 527-59
DOI
ScienceOn
|
14 |
Garzon J, Rodriguez-Munoz M, Torre-Madrid E, Sanchez-Blazquez P: Effector antagonism by the regulators of G protein signaling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychophatmacology 2005; 180: 1-11
|
15 |
Chasse SA, Dohlman HG: RGS proteins: G protein-coupled receptors meet their match. Assay Drug Dev Technol 2003; 1: 357-64
DOI
ScienceOn
|
16 |
Sanchez-Blazquez P, Rodriguez-Munoz M, Montero C, Garzon J: RGS-Rz and RGS9-2 proreins control mu-opioid receptor desensirization in CNS: the role of activated G subunits. Neurophamacology 2005; 48: 134-50
DOI
ScienceOn
|
17 |
Heplet JR Betman DM, Gilman AG, Kozasa T: RGS4 and GAIP are GTPase-activating proteins fot Gq and block activation of phospholipase C by t-thio-GTP-Gq . Proc Narl Acad Sci USA 1997; 94: 428-32
|
18 |
Snow BE, Krumins AM, Brothers GM, Lee SF, Wall MA, Chung S, et al: A G protein gamma subunit-like domain shared berween RGS 11 and othet RGS proteins specifies binding to Gbeta5 subunits. Proc Natl Acad Sci USA 1998; 95: 13307-12
|
19 |
Garzon J, Rodriguez-Mufioz M, Sanchez-Blazquez P: Morphine alters the selective association between mu-opioid teceptors and specific RGS proreins in mouse periaqueductal gtay matter. Neurophamacology 2005; 48: 853-68
DOI
ScienceOn
|
20 |
Kim KJ, Moriyama K, Han KR, Sharma M, Han X, Xie GX, et al: Differential expression of the regulator of G protein signaling RGS9 protein in nociceptive pathways of different age tats. Dev Brain Res 2005; 160: 28-39
DOI
ScienceOn
|
21 |
Xu H, Wang X, Wang J, Rothman RB: Opioid peptide receptor studies. 17. attenuation of chtonic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 ptotein in cells expressing the cloned mu opioid teceptot. Synapse 2004; 52: 209-17
DOI
ScienceOn
|
22 |
Garzon J, Rodriguez-Munoz M, Lopez-Fando A, Sanchez-Blazquez P: The RGSZ2 protein exists in a complex with -opioid receptors and regulates the desensitizing capacity of Gz ptoteins. Neuropsychopharmacology 2005; 30: 1632-48
DOI
ScienceOn
|
23 |
Zhong H, Neubig RR: Regularor of G protein signaling proteins: novel multifunctional drug tatgets. J Phatmacol Exp Ther 2001; 297: 837-45
|
24 |
Zachariou V, Georgescu D, Sanchez N, Rahman Z, DiLeone R, Berton O, et al: Essential role for RGS9 in opiate action. Proc Natl Acad Sci USA 2003; 100: 13656-61
|
25 |
Borgland SL: Acute opioid receptor desensirization and toletance: is there a link? Clin Exp Pharmacol Physiol 2001; 28: 147-54
DOI
ScienceOn
|
26 |
Nakagawa T, Minami M, Satoh M: Up-regulation of RGS4 mRNA by opioid receptor agonists in PC 12 cells expressing cloned - or K-opioid receptors. Eur J Pharmacol 2001; 433: 29-36
DOI
ScienceOn
|
27 |
Krumins AM, Barker SA, Huang C, Sunahara RK, Yu K, Wilkie TM, et al: Differentially regulated expression of endogenous RGS4 and RGS7. J Biol Chem 2004; 279: 2593-9
DOI
ScienceOn
|
28 |
Garzon J, Lopez-Fando A, Sanchez-Blazquez P: The R7 subfamily of RGS proteins assists tachyphylaxis and acute tolerance at mu-opioid receptors, Neuropsychopharmacology 2003; 28: 1983-90
DOI
|
29 |
Ikeda K, Kobayashi T, Kumanishi T, Yano R, Sora I, Niki H: Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? Neurosci Res 2002; 44: 121-31
DOI
ScienceOn
|
30 |
Thomas EA, Danielson PE, Sutcliffe JG: RGS9: A regulator of G-protein signaling with specific exptession in tat and mouse striatum. J Neurosci Res 1998; 52: 118-24
DOI
ScienceOn
|
31 |
Neubig RR, Siderovski DP: Regulatots of G-protein signalling as new central nervous system drug tatgets. Nat Rev Drug Discov 2002; 1: 187-97
DOI
|
32 |
Kieffet BL, Evans CJ: Opioid toletance-ln search of the holy grail. Cell 2002; 108: 587-90
DOI
ScienceOn
|
33 |
Popov S, Yu K, Kozasa T, Wilkie TM: The regulatots of G protein signaling (RGS) domains of RGS4, RGS10, and GAIP retain GTPase activating protein activity m vitto. Proc Narl Acad Sci USA 1997; 94: 7216-20
|
34 |
Garzon J, Rodriguez-Diaz M, Lopez-Fando A, Sanchez-Blazquez P: RGS9 proteins facilitate acute toletance to mu-opioid effects. Eut J Neurosci 2001; 13: 801-11
DOI
ScienceOn
|
35 |
Liu J, Anand KJS: Protein kinases modulate the cellular adaptations associated with opioid toletance and dependence. Brain Res Rev 2001; 38: 1-19
DOI
ScienceOn
|
36 |
Sierra DA, Gilbert DJ, Householder D, Grishm NV, Yu K, Ukidwe P, et al: Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 2002; 79: 177-85
DOI
ScienceOn
|
37 |
Garzon J, Lopez-Fando A, Sanchez-Blazquez P: Activation of mu-opioid receptots ttansfers control of G subunits to the regu-lator of G-protein signaling RGS9-2. Role in receptor desensitiza-tion. J Biol Chem 2005; 280: 8951-60
DOI
ScienceOn
|
38 |
Simon MI, Strathmann MP, Gautam N: Diversity of G proteins in signal ttansduction. Science 1991; 252: 802-8
DOI
|
39 |
Goldstein A, Naidu A: Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 1989;36: 265-72
|
40 |
Xie GX, Palmer PP: RGS proteins: new players in the field of opioid signaling and toletance mechanisms. Anesth Analg 2005; 100: 1034-42
DOI
ScienceOn
|
41 |
Lopez-Fando A, Rodriguez-Munoz M, Sanchez-Blazquez P, Garzon J: Expression of neural RGS-R7 and G/ proteins in response to acute and chronic morphine. Neuropsychopharmacology 2005; 48: 134-50
|
42 |
Gamier M, Zaratin PF, Ficalora G, Valente M, Fontanella L, Rliee MH, et al: Up-regulation of regulator of G protein signaling 4 exptession in a model of neuropathic pain and insensi-tivity to morphine. J Pharmacol Exp Ther 2003; 304: 1299-306
DOI
ScienceOn
|
43 |
Burchett SA: In through the out door: nuclear localization of the regulatots of G protein signaling. J Neurochem 2003; 87: 551-9
DOI
ScienceOn
|
44 |
Kikuchi A: Modulation of Wnt signaling by Axin and Axil. Cytokine Growth Factor Rev 1999; 10: 255-65
DOI
ScienceOn
|
45 |
Elenko E, Fischer T, Niesman I, Harding T, McQuistan T, Von Zasttow M, et al: Spatial regulation of Gi protein signaling in cla-thtin-coated membrane microdomains containing GAIP. Mol Pharmacol 2003; 64: 11-20
DOI
ScienceOn
|
46 |
Gold SJ, Ni YG, Dohlman HG, Nesrler EJ: Regulatots of G-protem signaling (RGS) proteins: region-specific expression of nine subrypes in rat brain. J Neurosci 1997; 17: 8024-37
DOI
|
47 |
De Vties L, Elenko E, Hubler L, Jones TL, Faquhar MG: GAIP is membrane-anchored by palmitoylation and interacts with the activated (GTP-bound) form of G subunits. Proc Natl Acad Sci USA 1996; 93: 15203-08
|
48 |
Ippolito DL, Temkin PA, Rogalski SL, Chavkin C: N-terminal tyrosine tesidues within the potassium channel Kir3 modulate GTPase activity of Gi. J Biol Chem 2002; 277: 32692-6
DOI
ScienceOn
|
49 |
Gold SJ, Han MH, Hetman AE, Ni YG, Pudiak CM, Aghaja-nian GK, et al: Regulation of RGS ptoteins by chronic morphine in rat locus coeruleus. Eur J Neurosci 2003; 17: 971-80
DOI
ScienceOn
|